24 X 7 online support

indiaurolift@gmail.com

Contact Us

+91-9815978530, +91-7999634444 ,
+91 - 7999632222

Treatment Comparison

How UroLift Stands Apart from
Other BPH Treatments

The UroLift System is a clinically proven solution for men seeking an effective alternative to medications or invasive surgery. It is the only BPH treatment that requires no ongoing medication, no heating, cutting, or removal of prostate tissue.

This innovative system provides reliable symptom relief with minimal risk of side effects, while preserving natural sexual function*¹.

What Are the Treatment Options?

Feature / Factor
UroLift
iTIND
Rezūm
Procedure Type
Implant to lift prostate tissue
Temporary implant reshaping urethra
Steam (water vapor) ablation
Anesthesia
Local, sometimes sedation
Local or sedation
Local or mild sedation
Recovery Time
Short resume activities in days
Moderate some discomfort during device
1–2 weeks for full recovery
Symptom Relief
Rapid (often within 2 weeks)
Gradual (4–6 weeks)
Gradual (up to 3 months)
Effect on Sexual Function
Preserves ejaculatory function
Preserves sexual function
Preserves sexual function
Hospital Stay
Outpatient (same-day)
Outpatient; device removed after 5 days
Outpatient (same-day)

Preservation of Sexual Function

The UroLift System is the only major BPH procedure clinically proven not to cause new or lasting sexual dysfunction*²,⁴,⁵.

A global study involving over 13,000 men aged 40–80 across 29 countries revealed that nearly half consider sexual activity to be very to extremely important⁶. Erectile dysfunction can lead to anxiety, depression, reduced self-esteem, and a decline in overall quality of life⁷.

When selecting a BPH treatment, it is therefore essential to consider the potential effects on both ejaculatory and erectile function, as these factors play a major role in long-term patient satisfaction.

Low Retreatment Rate

The UroLift System demonstrates a consistently low rate of surgical retreatment among BPH procedures — approximately 13.6% over five years, equating to around 2–3% per year¹.

In the pivotal clinical study, no additional surgical interventions were required during the first postoperative year for bladder neck contracture, bleeding, or stress incontinence following UroLift treatment⁴.

Patient Experience